MUGARD
DEAD

Serial Number

85116721

Owner

ABEONA THERAPEUTICS, INC.

Attorney

Katherine P. Califa

First Use Date

Dec 25, 2006

Filing Date

Aug 26, 2010

Add to watchlist:

No watchlists yet
View on USPTO

MUGARD Trademark

Serial Number: 85116721 • Registration: 3950832

MUGARD is a trademark filed by ABEONA THERAPEUTICS, INC. on August 26, 2010. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ABEONA THERAPEUTICS, INC. (23 trademarks)

3333 LEE PARKWAY
DALLAS, TX 75219

Entity Type: 03

AMAG PHARMACEUTICALS, INC. (40 trademarks)

100 Hayden Avenue
Lexington, MA 02421

Entity Type: 03

PlasmaTech Biopharmaceuticals, Inc. (2 trademarks)

4848 Lemmon Avenue
Dallas, TX 75219

Entity Type: 03

Access Pharmaceuticals (2 trademarks)

2600 Stemmons Freeway
Dallas, TX 75207

Entity Type: 03

Trademark Details

Filing Date

August 26, 2010

Registration Date

April 26, 2011

First Use Anywhere

December 25, 2006

First Use in Commerce

December 25, 2006

Published for Opposition

February 8, 2011

Cancellation Date

November 19, 2021

Goods & Services

[ Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; ] Pharmaceutical preparations for the treatment and prevention of oral [ and esophageal ] mucositis [ ; drug delivery agents consisting of compounds that facilitate delivery of a wide range of active pharmaceuticals to the oral mucosa ]

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Nov 19, 2021 CAEX
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 24, 2021 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 10, 2020 ASCK
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 26, 2020 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 22, 2020 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 19, 2016 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 19, 2016 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 19, 2016 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 10, 2016 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 26, 2016 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 8, 2015 ASGN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 26, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 26, 2015 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 18, 2015 ASGN
REGISTERED-PRINCIPAL REGISTER
Apr 26, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 8, 2011 NPUB
PUBLISHED FOR OPPOSITION
Feb 8, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 6, 2011 PREV
ASSIGNED TO LIE
Jan 6, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 9, 2010 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 9, 2010 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 9, 2010 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 9, 2010 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 9, 2010 CNEA
ASSIGNED TO EXAMINER
Dec 8, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2010 NWOS
NEW APPLICATION ENTERED
Aug 30, 2010 NWAP